F. Trinkmann (Heidelberg, Germany), A. Lopez Giraldo (Castelldefels, Spain)
Research priorities in alpha-1 antitrypsin deficiency (AATD) for healthcare professionals
M. Barrecheguren Fernandez (Barcelona, Spain), M. Sucena (Porto, Portugal), K. O´hara (UK, United Kingdom), M. Wilkens (Germany, Germany), J. Boyd (Sheffield, United Kingdom), E. Kolda (Poznan, Poland), A. Turner (Birmingham, United Kingdom), G. Mcelvaney (Dublin, Ireland), I. Ferrarotti (Pavia, Italy), J. Stolk (Leiden, Netherlands), J. Chorostowska-Wynimko (Warsaw, Poland), R. Stockley (Birmingham, United Kingdom), T. Greulich (Marburg, Germany), M. Miravitlles (Barcelona, Spain)
|   |
Prevalence of alpha-1 antitrypsin deficiency (AATD) in Greater Glasgow and Clyde (GG&C) and current practises
F. Catterall (Glasgow, United Kingdom), D. Anderson (Glasgow, United Kingdom)
| |
ARE THERE DIFFERENCES IN EXERCISE CAPACITY BY GENDER IN COPD PATIENTES?
V. Almadana Pacheco (Sevilla, Spain), C. Benito Bernáldez (Sevilla, Spain), L. Marín Barrera (Sevilla, Spain), R. Ayerbe García (Sevilla, Spain)
| |
Phenotypic characteristics of asthmatic patients with distal airways obstruction
n. guediri (tunisie, Tunisia), A. Ben Mansour (tunisie, Tunisia), S. Ben Saad (tunisie, Tunisia), S. Essebaa (tunisie, Tunisia), R. Jebali (tunisie, Tunisia), H. Daghfous (tunisie, Tunisia), T. Fatma (tunisie, Tunisia)
| |
Characterization of a patient population phenotyped for alpha-1-antitrypsin
M. Conde (Vila Real, Portugal), B. Conde (Vila Real, Portugal), C. Parra (Vila Real, Portugal), A. Vale (Vila Real, Portugal), A. Fernandes (Vila Real, Portugal)
| |
Correlation between cardiorespiratory coupling and six-minute walking tests in patients with chronic obstructive pulmonary disease
Y. Huang (Taoyuan, Taiwan), T. Lin (Taoyuan, Taiwan), H. Wu (Durham, United States of America), P. Chang (Taoyuan, Taiwan), C. Lo (Taoyuan, Taiwan), S. Lin (Taoyuan, Taiwan), H. Lin (Taoyuan, Taiwan), Y. Lo (Taoyuan, Taiwan)
| |
Physical activity and cardiac autonomic function in patients with COPD, a cross-sectional analysis
L. Delgado Ortiz (Barcelona, Spain), A. Arbillaga-Etxarri (Donostia-San Sebastian, Spain), D. Rodríguez (Barcelona, Spain), E. Gimeno-Santos (Barcelona, Spain), A. Barberan-Garcia (Barcelona, Spain), R. Rodríguez-Roisin (Barcelona, Spain), E. Balcells (Barcelona, Spain), J. Vilaró (Barcelona, Spain), J. Garcia-Aymerich (Barcelona, Spain)
| |
Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
N. Schafauser (São Carlos, Brazil), D. Kawakami (São Carlos, Brazil), A. Heubel (São Carlos, Brazil), E. Kabbach (São Carlos, Brazil), N. Sgarbosa (São Carlos, Brazil), V. Di-Lorenzo (São Carlos, Brazil), A. Borghi-Silva (São Carlos, Brazil), R. Mendes (São Carlos, Brazil)
| |
Body mass index in COPD: what relationship?
S. Mokaddem Mohsen (Tunis, Tunisia), S. Chakroun (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
| |
Czech national alpha-1 antitrypsin registry
J. Chlumsky (Praha 4, Czech Republic), K. Kusalova (Brno, Czech Republic)
| |
RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES
B. Alcazar Navarrete (Loja, Spain), S. Calvo Rodriguez (Sevilla, Spain), L. Carrasco Hernandez (Sevilla, Spain), P. Romero Palacios (Granada, Spain), O. Ruiz Rodriguez (Loja, Spain), J. Lopez Campos (Sevilla, Spain)
| |
Descriptive analysis of patients admitted due to COPD exacerbation (COPDE) and COPD-pneumonia.
I. Muñoz Ramirez (Cádiz, Spain), A. Marín Andreu (Cádiz, Spain), C. España Domínguez (Cádiz, Spain), M. Morales González (Cádiz, Spain), E. Vázquez Gandullo (Cádiz, Spain), A. Arnedillo Muñoz (Cádiz, Spain)
| |
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
A. Ben Saad (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia)
| |
COPD Assessment Test (CAT) scores following a digital health intervention
L. Kaye (San Francisco, United States of America), R. Gondalia (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)
| |
The relationship between vitamin D deficiency and the main characteristics of COPD patients
A. Suleymanova (Moscow, Russian Federation), I. Baranova (Moscow, Russian Federation)
| |
Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD.
K. Klester (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), A. Balitskaya (Barnaul, Russian Federation), I. Sheremetyeva (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), M. Alwash (Yoshkar-Ola, Russian Federation)
| |
Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?
S. Liška (Zagreb, Croatia), A. Vidakovic (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia)
| |
Clinical features and factors associated current smoking in stage I COPD
H. Lin (Taipei, Taiwan)
| |
Key findings and quality improvement recommendatons from the national asthma and COPD audit programme (NACAP) primary care audit April 2017- September 2018
E. Imoedemhe (London, United Kingdom), K. Hickman (London, United Kingdom)
| |